Experiments with LCs from these mice showed that knock-down of Evi1 per se reduced LSCe/LSC abundance, quiescence, and activity (the first demonstration of a key role of Evi1 in AML LSCs), and additionally abolished the stemness promoting effects of atRA [17]. The gene discussed is MECOM; the disease is acute myeloid leukemia.